Microbiological efficiency of the combinations of two carbapenems against antibiotic resistant Klebsiella pneumoniae strains
Open Access
- 23 May 2021
- journal article
- research article
- Published by EKOlab in Russian Clinical Laboratory Diagnostics
- Vol. 66 (5) , 304-309
Abstract
Combined antibiotic therapy is widely used for infections caused by carbapenem-resistant K. pneumoniae. The objective of this work was to identify the synergistic activity of combinations of two carbapenems against multidrug- and extensively drug-resistant K. pneumoniae strains producing various types of carbapenemases. For 60 antibiotic-resistant K. pneumoniae strains isolated in 8 cities of Belarus, the minimum inhibitory concentrations (MIC) of colistin and carbapenems were determined by subsequent broth microdilution method, and the genes of carbapenemases and phosphoethanolamine transferases were detected. The checkerboard method was used to determine the sensitivity to the combination of ertapenem and doripenem. High MIC values of carbapenems were revealed for NDM carbapenemase-producing strains (MIC50 of meropenem 64 mg/L, MIC50 of doripenem 64 mg/L). Doripenem was more active; MIC of doripenem ≤ 16 mg/L (low level of resistance) was determined in 28 (46.7%) strains, MIC of meropenem ≤ 16 mg/L - in 8 (13.3% of strains). The effect of potentiating the activity of doripenem with ertapenem at a fixed pharmacokinetic / pharmacodynamic concentration was observed for 20.0% of the strains producing KPC carbapenemase and 29.0% of the strains producing OXA-48 carbapenemase. The potentiating effect was independent of the presence of colistin resistance. Thus, the ability of ertapenem to potentiate the antimicrobial activity of doripenem and meropenem against some of the strains producing serine carbapenemases (KPC and OXA-48) was confirmed. The necessity of routine determination of the true MIC values of carbapenems was shown to optimize their dosage regimens and select the combination antibiotic therapy regimens.Keywords
This publication has 21 references indexed in Scilit:
- The reasons why Klebsiella pneumoniae becomes a leading opportunistic pathogenClinical Microbiology and Antimicrobial Chemotherapy, 2020
- Colistin Resistance in Enterobacterales Strains – A Current ViewPolish Journal of Microbiology, 2019
- Global Burden of Colistin-Resistant Bacteria: Mobilized Colistin Resistance Genes Study (1980–2018)Microorganisms, 2019
- Antimicrobial resistance of nosocomial Enterobacterales isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”Clinical Microbiology and Antimicrobial Chemotherapy, 2019
- Role of Double-Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae: A Single-Center, Observational StudyBioMed Research International, 2018
- Critical Review of Double-Carbapenem Therapy for the Treatment of Carbapenemase-Producing Klebsiella pneumoniaeAnnals of Pharmacotherapy, 2018
- In vitro evaluation of double-carbapenem combinations against OXA-48-producing Klebsiella pneumoniae isolates using time–kill studiesJournal of Medical Microbiology, 2018
- Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on MortalityClinical Infectious Diseases, 2016
- Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2016
- Treatment of carbapenem-resistantKlebsiella pneumoniae: the state of the artExpert Review of Anti-infective Therapy, 2013